Alterations in functional brain network structure induced by subchronic phencyclidine (PCP) treatment parallel those seen in schizophrenia

Neil Dawson; Des Higham; Judith Pratt; Brian Morris

doi:10.1016/j.schres.2010.02.349

Alterations in functional brain network structure induced by subchronic phencyclidine (PCP) treatment parallel those seen in schizophrenia

Neil Dawson, Des Higham, Judith Pratt, Brian Morris

Research output: Contribution to journal › Conference Contribution › peer-review

246 Downloads (Pure)

Abstract

Abstract of poster presentation shown at the 2nd Biennial Schizophrenia International Research Conference on Alterations in functional brain network structure induced by subchronic phencyclidine (PCP) treatment parallel those seen in schizophrenia.

Original language	English
Pages (from-to)	234-235
Number of pages	2
Journal	Schizophrenia Research
Volume	117
Issue number	2-3
DOIs	https://doi.org/10.1016/j.schres.2010.02.349
Publication status	Published - Apr 2010
Event	2nd Biennial Schizophrenia International Research Conference - Florence, Italy Duration: 10 Apr 2010 → 14 Apr 2010

Keywords

brain network
schizophrenia
PCP
subchronic phencyclidine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.schres.2010.02.349

NDawson 2010Submitted manuscript, 92.4 KB

1 Literature review

Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
Pratt, J., Winchester, C., Dawson, N. & Morris, B., Jul 2012, In: Nature Reviews Drug Discovery . 11, 7, p. 560-579 20 p.
Research output: Contribution to journal › Literature review › peer-review
134 Citations (Scopus)

18 Downloads (Pure)

Cite this

@article{063ad0eca5564fbf89808facf86bfb13,

title = "Alterations in functional brain network structure induced by subchronic phencyclidine (PCP) treatment parallel those seen in schizophrenia",

abstract = "Abstract of poster presentation shown at the 2nd Biennial Schizophrenia International Research Conference on Alterations in functional brain network structure induced by subchronic phencyclidine (PCP) treatment parallel those seen in schizophrenia.",

keywords = "brain network, schizophrenia, PCP, subchronic phencyclidine",

author = "Neil Dawson and Des Higham and Judith Pratt and Brian Morris",

year = "2010",

month = apr,

doi = "10.1016/j.schres.2010.02.349",

language = "English",

volume = "117",

pages = "234--235",

journal = "Schizophrenia Research",

issn = "0920-9964",

number = "2-3",

note = "2nd Biennial Schizophrenia International Research Conference ; Conference date: 10-04-2010 Through 14-04-2010",

}

TY - JOUR

T1 - Alterations in functional brain network structure induced by subchronic phencyclidine (PCP) treatment parallel those seen in schizophrenia

AU - Dawson, Neil

AU - Higham, Des

AU - Pratt, Judith

AU - Morris, Brian

PY - 2010/4

Y1 - 2010/4

N2 - Abstract of poster presentation shown at the 2nd Biennial Schizophrenia International Research Conference on Alterations in functional brain network structure induced by subchronic phencyclidine (PCP) treatment parallel those seen in schizophrenia.

AB - Abstract of poster presentation shown at the 2nd Biennial Schizophrenia International Research Conference on Alterations in functional brain network structure induced by subchronic phencyclidine (PCP) treatment parallel those seen in schizophrenia.

KW - brain network

KW - schizophrenia

KW - PCP

KW - subchronic phencyclidine

U2 - 10.1016/j.schres.2010.02.349

DO - 10.1016/j.schres.2010.02.349

M3 - Conference Contribution

SN - 0920-9964

VL - 117

SP - 234

EP - 235

JO - Schizophrenia Research

JF - Schizophrenia Research

IS - 2-3

T2 - 2nd Biennial Schizophrenia International Research Conference

Y2 - 10 April 2010 through 14 April 2010

ER -

Alterations in functional brain network structure induced by subchronic phencyclidine (PCP) treatment parallel those seen in schizophrenia

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Research output

Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap

Cite this